SDS and inflammatory bowel disease: Therefore, patients with inflammatory bowel disease (IBD) often suffer from gut microbiota dysbiosis accompanied by microbial diversity declines and a lower relative abundance of Firmicutes, leading to the impaired function in metabolizing primary BAs via a reduction in BSH and HSDH activity [16,86].